IR, affecting approximately 70% of patients, leads to compensatory hyperinsulinemia, which stimulates ovarian androgen secretion while suppressing hepatic sex hormone-binding globulin (SHBG) synthesis. The gene discussed is SHBG; the disease is hyperinsulinism.